When associated with the 2-AHE2P monophosphoester, a protective effect is observed for normal FN1, not causing accentuated cytotoxicity or modulating the distribution of cells in the phases of the cell cycle and mitochondrial electrical potential, thus improving the therapeutic index by continuing to show antitumor and antiproliferative effects on tumor cells. Here, FN1 is linked to neoplasm.